Yakult Expands Its European Presence with New Research Facility
Yakult, renowned for its contributions to the gut health sector, has announced the opening of a new research facility in Wageningen, Netherlands. This marks the company's first global R&D centre outside of Japan, enabling collaboration with leading scientists in the fields of food, nutrition, and life sciences. The facility aims to develop new product concepts, addressing diverse consumer needs and promoting innovation.
Established in 1935, Yakult has grown into a global enterprise with operations in 40 countries and regions, producing approximately 38 million bottles daily. Its European headquarters in Almere, near Amsterdam, currently manufactures 3.6 million bottles every day for 13 markets across Europe.
Despite a 2.7% decline in consolidated net sales to ¥486.4 billion (around $3.05 billion) in the fiscal year ending March 2026, Yakult sees international markets as a primary growth area. Sales in Europe increased by 4.7% year-on-year to ¥12.7 billion ($78.8 million) in FY2025, although the region reported an operating loss of ¥91 million ($572K).
Yakult faces fierce competition in the functional health sector from companies such as Danone, which has significant market influence with its Actimel product. Danone's sales reached €27.3 billion in 2025, with a robust international presence. Yakult's effort to expand its market share reflects a strategy to maintain and enhance its competitive edge in the growing functional beverages sector.
In addition to its new facility, Yakult has introduced a plant-based product, Yakult Vitals, into the European market. This soy-based drink is enriched with vitamin D, calcium, magnesium, and zinc to support immunity and digestion, and is part of Yakult's strategy to diversify its product range and draw new consumer groups.
Shinji Yamaguchi, Yakult's managing director for the UK and Ireland, emphasized the importance of straightforward and well-substantiated claims in the functional food and drink market. He noted the growing consumer interest in gut health, driven by scientific advancements and media coverage. Yamaguchi stated that gut health discussions have become mainstream, highlighting the company's continuing focus on science-led innovation grounded in the pioneering research of Dr. Minoru Shirota, Yakult's founder.
